Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP772491.RAWqXRjM9s-nb1rxhUmRmlyFWuLQveEJGxl2ecptqJgOE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP772491.RAWqXRjM9s-nb1rxhUmRmlyFWuLQveEJGxl2ecptqJgOE130_assertion type Assertion NP772491.RAWqXRjM9s-nb1rxhUmRmlyFWuLQveEJGxl2ecptqJgOE130_head.
- NP772491.RAWqXRjM9s-nb1rxhUmRmlyFWuLQveEJGxl2ecptqJgOE130_assertion description "[In patients studied for concurrent methylation of several promoters, t-MDS/AML were significantly more frequently hypermethylated in 2 or more promoter regions than de novo MDS or AML suggesting that promoter hypermethylation of genes involved in cell cycle control, apoptosis and DNA repair pathways is a frequent finding in t-MDS/AML and may contribute to secondary leukemogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772491.RAWqXRjM9s-nb1rxhUmRmlyFWuLQveEJGxl2ecptqJgOE130_provenance.
- NP772491.RAWqXRjM9s-nb1rxhUmRmlyFWuLQveEJGxl2ecptqJgOE130_assertion evidence source_evidence_literature NP772491.RAWqXRjM9s-nb1rxhUmRmlyFWuLQveEJGxl2ecptqJgOE130_provenance.
- NP772491.RAWqXRjM9s-nb1rxhUmRmlyFWuLQveEJGxl2ecptqJgOE130_assertion SIO_000772 19874806 NP772491.RAWqXRjM9s-nb1rxhUmRmlyFWuLQveEJGxl2ecptqJgOE130_provenance.
- NP772491.RAWqXRjM9s-nb1rxhUmRmlyFWuLQveEJGxl2ecptqJgOE130_assertion wasDerivedFrom befree-2016 NP772491.RAWqXRjM9s-nb1rxhUmRmlyFWuLQveEJGxl2ecptqJgOE130_provenance.
- NP772491.RAWqXRjM9s-nb1rxhUmRmlyFWuLQveEJGxl2ecptqJgOE130_assertion wasGeneratedBy ECO_0000203 NP772491.RAWqXRjM9s-nb1rxhUmRmlyFWuLQveEJGxl2ecptqJgOE130_provenance.